Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017.

The annual accounts and annual report for the financial year 2017 are enclosed with this notification and made available on the company's website, www.photocure.com.  

For further information, please contact:

Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email: ed@photocure.no

About Photocure ASA
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com, www.hexvix.com, www.cysview.com.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Annual report 2017


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Photocure ASA via Globenewswire
Grafico Azioni Invesco Water Resources ... (NASDAQ:PHO)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Invesco Water Resources ...
Grafico Azioni Invesco Water Resources ... (NASDAQ:PHO)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Invesco Water Resources ...